Association between Elevated Hemoglobin A1c Levels and the Outcomes of Patients with Small-Artery Occlusion: A Hospital-Based Study

PLoS One. 2016 Aug 3;11(8):e0160223. doi: 10.1371/journal.pone.0160223. eCollection 2016.

Abstract

Introduction: Abnormal glucose metabolism is an independent risk factor for poor outcome following acute ischemic stroke. However, the relationship between initial hemoglobin A1c level and functional outcome (defined by modified Rankin Scale scores) following small-artery occlusion, a subtype of ischemic stroke, is unknown. The aim of the present study was to evaluate this association among patients diagnosed with small-artery occlusion.

Materials and methods: Data on 793 patients diagnosed with small-artery occlusion from October 25, 2012 to June 30, 2015 were collected from the stroke registry of the Department of Neurorehabilitation of HuanHu Hospital. Hemoglobin A1c values at admission were classified into three groups according to tertiles (<5.9,5.9to<6.7, and≥6.7). We used receiver operating characteristics curves to investigate the predictive value of hemoglobin A1c and examined the relationship between hemoglobin A1c levels at admission and modified Rankin Scale scores using univariate and multivariate analyses.

Results: The area under the curve was 0.570 (95%CI, 0.509-0.631; P = 0.023). Patients in the highest HbA1c stratification (≥6.7) had a significantly higher risk of an unfavorable outcome than patients in the lowest stratification (<5.9; adjusted odds ratio, 2.099; 95%CI, 1.160-3.798; P = 0.014). However, a significant association was not seen in the middle stratification (5.9 to <6.7; P = 0.115).

Conclusions: Elevated hemoglobin A1c level on admission was adversely associated with functional outcomes 3 months after stroke onset among patients presenting with small-artery occlusion.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Arteries / pathology*
  • Biomarkers / blood
  • Cerebrovascular Disorders / blood
  • Cerebrovascular Disorders / diagnosis
  • Cerebrovascular Disorders / rehabilitation
  • Constriction, Pathologic / blood*
  • Constriction, Pathologic / diagnosis
  • Constriction, Pathologic / rehabilitation
  • Female
  • Glycated Hemoglobin / metabolism*
  • Humans
  • Male
  • Middle Aged
  • Prognosis
  • Recovery of Function
  • Retrospective Studies
  • Sensitivity and Specificity
  • Stroke / blood
  • Stroke / diagnosis*
  • Stroke Rehabilitation

Substances

  • Biomarkers
  • Glycated Hemoglobin A
  • hemoglobin A1c protein, human

Grants and funding

This study was generously supported by grants from Tianjin Public Health Bureau (2013KG122) to J.W. (http://www.tjwsj.gov.cn), General Administration of Sport of China (2015B098) to J.W. (http://www.sport.gov.cn), and Tianjin Municipal Science and Technology Commission (13JCYBJC23200) to J.W. (http://www.tstc.gov.cn) and (13ZCZDSY01600) to X.T. (http://www.tstc.gov.cn).